We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
(Scientific American/STAT) Mar 24, 2017 - It was the study that launched hundreds of scientific rebuttals, insinuations that the authors had been paid off by the chemical industry, and charges that it was a “massive” stunt “hidden behind fancy numbers of doubtful quality.”
(Medscape Medical News) Mar 24, 2017 - It's only March, but the National Comprehensive Cancer Network (NCCN) has already issued five updates of its 2017 non–small cell lung cancer (NSCLC) guidelines, as clinical practice continues to rapidly change, according to presenters here at the group's annual meeting.
(CureToday.com) Mar 23, 2017 - Bavencio (avelumab), a PD-L1-inhibitor, gained approval by the Food and Drug Administration (FDA) for some patients with Merkel cell carcinoma.
(ACS) Mar 23, 2017 - The American Cancer Society and a coalition of leading professional, government and non-governmental organizations are coming together to form the National Lung Cancer Roundtable to accelerate the nation's efforts to reduce mortality from lung cancer.
(STAT Plus) Mar 23, 2017 - Among the drug industry’s least-escapable buzzphrases is “value-based contracting,” a system under which payers shell out for pricey drugs only when they work, creating a theoretical win-win that increases access and cuts costs all the while.
(AMP) Mar 22, 2017 - The Association for Molecular Pathology (AMP), the premier global, non-profit molecular diagnostics professional society, today published consensus recommendations to help clinical laboratory professionals achieve high-quality sequencing results and deliver better care for cancer patients.
(FDA.gov) Mar 23, 2017 - The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.
(STAT Plus) Mar 22, 2017 - It’s been a rough nine months for Bristol-Myers Squibb, between disappointing trial results, mounting competition, and some unwelcome attention from activist investors.
(ASCO) Mar 22, 2017 - The U.S. cancer care delivery system is undergoing profound changes to better meet the needs of people with cancer, but persistent hurdles threaten to slow progress, according to the American Society of Clinical Oncology’s (ASCO) fourth annual State of Cancer Care in America report released today.
(PharmaTimes [UK]) Mar 23, 2017 - An experimental therapy in development by Shire for patients with the rare blood disorder hereditary thrombotic thrombocytopenic purpura (hTTP) has been granted a fast track designation by the US Food and Drug Administration.